About Biotrial
Biotrial, founded in 1989 in France, brings over 30 years of expertise in conducting clinical trials for pharmaceutical and biotech companies globally. In 2015, Biotrial expanded to Canada and the United States, where Biotrial Inc. now operates. Biotrial focuses primarily on Phase 1 clinical trials and sometimes patients’ trials.
Our state-of-the-art Biotrial Medical Research Center in Newark, NJ, conducts clinical research with healthy volunteers and, sometimes, patients. We serve clients ranging from global companies to innovative startups. With convenient access to the greater New York City area, our facility is designed to meet the highest safety and security standards.
Our Expertise in Clinical Trials
Biotrial in Newark, NJ primarily conducts Phase 1 clinical trials with healthy volunteers. These trials focus on assessing the safety and tolerance of new drugs, with some volunteers receiving the drug and others a placebo.
We also sometimes test innovative medical devices, such as connected t-shirts and headbands.
Biotrial is proud to be one of the most trusted clinical research centers on the United States East Coast.
Why Choose Biotrial?
At Biotrial, we are committed to maintaining the highest standards of research excellence. Our clinical research center is trusted by many of the world’s leading pharmaceutical companies and Biotechs.
- We prioritize volunteer satisfaction and comfort.
- Our highly trained staff is dedicated to providing exceptional care.
- We continuously invest in our infrastructure to stay at the forefront of medical research.
Safety Comes First
At Biotrial, volunteer safety is our primary concern. We adhere to the Good Clinical Practice (GCP) standards, ensuring the highest level of integrity in all clinical research. Our goal is to contribute to advancing medical science while keeping volunteer safety and comfort our top priority.
We conduct comprehensive medical examinations before, during, and after each study. Our team of Principal Investigators ensures that all clinical trials follow approved protocols.
We also implement fingerprint verification to ensure participants do not enroll in multiple trials simultaneously, safeguarding their well-being and maintaining the integrity of the studies.
Regulatory Compliance
In the U.S., the Food and Drug Administration (FDA) regulates clinical trials to protect participants and ensure they have reliable information to make informed decisions. The Institutional Review Board (IRB), a designated committee, reviews and monitors all biomedical research involving human subjects.
Both regulatory bodies must approve every trial protocol to ensure ethical compliance. A human clinical trial is authorized only if laboratory and animal studies show favorable results.
Biotrial strictly follows all decisions made by the FDA and Institutional Review Board (IRB).
Full Transparency and Privacy Protection
We believe in full transparency throughout the clinical trial process. During the screening visit, participants receive informed consent information and can ask as many questions as needed. This step fosters trust and ensures a clear understanding of the clinical trial process.
We also respect and protect the privacy of our volunteers. We adhere to the Health Insurance Portability and Accountability Act (HIPAA), ensuring that all personal and medical information remains confidential.
Join Us in Advancing Medical Research
Participating in a clinical trial at Biotrial, you help shape the future of healthcare. Together, we are working to provide advanced treatments for future generations.
